Goldman Sachs’s Uranium Royalty Corp UROY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$794K Buy
285,455
+88,041
+45% +$309K ﹤0.01% 5399
2026
Q1
$721K Buy
197,414
+31,974
+19% +$131K ﹤0.01% 5329
2025
Q4
$586K Buy
165,440
+28,576
+21% +$112K ﹤0.01% 5496
2025
Q3
$589K Buy
136,864
+10,361
+8% +$31.3K ﹤0.01% 5411
2025
Q2
$316K Buy
126,503
+22,260
+21% +$45K ﹤0.01% 5413
2025
Q1
$183K Buy
104,243
+21,118
+25% +$45.2K ﹤0.01% 5659
2024
Q4
$182K Buy
83,125
+18,165
+28% +$46.7K ﹤0.01% 5668
2024
Q3
$159K Buy
64,960
+1,012
+2% +$2.28K ﹤0.01% 5508
2024
Q2
$144K Buy
63,948
+23,277
+57% +$57.8K ﹤0.01% 5340
2024
Q1
$97.2K Buy
+40,671
New +$116K ﹤0.01% 5251

Other funds holding UROY

Goldman Sachs's UROY Position: Q2 2026 in Review

Goldman Sachs increased its Uranium Royalty Corp (UROY) stake by 45% in Q2 2026, buying an estimated $309K and bringing the position to 285,455 shares worth $794K. The position accounts for ﹤0.01% of the portfolio, ranked #5399.

Goldman Sachs first reported a position in UROY in Q1 2024 and has held it in 10 quarters since. 112 funds tracked by Wall St. Rank hold UROY as of Q2 2026.

  • Goldman Sachs held 285,455 shares of Uranium Royalty Corp worth $794K as of Q2 2026.
  • Goldman Sachs bought 88,041 Uranium Royalty Corp shares in Q2 2026, an estimated $309K.
  • Uranium Royalty Corp made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #5399 holding.
  • Goldman Sachs first reported a position in Uranium Royalty Corp in Q1 2024 and has held it in 10 quarters since.
  • 112 funds tracked by Wall St. Rank held Uranium Royalty Corp as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.